This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The Oxford MedTech Society is a vibrant student-led community dedicated to exploring the transformative potential of medicaltechnology. Exec Summary: Nelson Advisors Partner Lloyd Price delivered the inaugural talk to the Oxford University MedTech society on Monday 27th January 2025.
The Oxford MedTech Society is a vibrant student-led community dedicated to exploring the transformative potential of medicaltechnology. Exec Summary: Nelson Advisors Partner Lloyd Price has been invited to mentor and advise students at the Oxford University MedTech society.
a medicaltechnology company with a vision to eliminate infusion-related patient harm, was founded in 2012 to develop innovative solutions that transform infusion delivery. This content is copyrighted strictly for Electronic Health Reporter. Ivenix, Inc.,
About Glaukos: Glaukos ( www.glaukos.com ) is an ophthalmic pharmaceutical and medicaltechnology company focused on developing and commercializing novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases.
Prior to joining HeartBeam, Deborah was Director of Regulatory Affairs Neuromodulation, at LivaNova, a global medical device company creating neuromodulation devices and cardiopulmonary products, developing and implementing the regulatory strategies for various Class III devices. CEO and Founder of HeartBeam.
Some of the most notable M&A deals that have occurred in the medical devices industry are: Medtronic's acquisition of Covidien: In January 2015, Medtronic, a leading medicaltechnology company, acquired Covidien, an Irish-based medical device manufacturer, in a deal worth approximately $49.9
The Company (NYSE:OWLT), a small-cap healthcare growth equity, offers FDA-authorized medical and consumer pediatric wearables and an integrated HD visual and audio camera that provide real-time data and insights to parents who safeguard health, optimize wellness, and ensure peaceful sleep for their children.
Some of the most notable M&A deals that have occurred in the medical devices industry are: Medtronic's acquisition of Covidien: In January 2015, Medtronic, a leading medicaltechnology company, acquired Covidien, an Irish-based medical device manufacturer, in a deal worth approximately $49.9
We organize all of the trending information in your field so you don't have to. Join 48,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content